Stonepine Capital Management, LLC 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-23 8:08 pm Purchase |
2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO |
Stonepine Capital Management, LLC | 1,916,666 5.200% |
1,916,666 (New Position) |
Filing |